Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2009 Nov 26.

Published in final edited form as: Atherosclerosis. 2008 Feb 21;201(1):43–52. doi: 10.1016/j.atherosclerosis.2008.01.018

Treatment group comparisons of cellular outcomes. Data are expressed as mean +/−SEM; p-values ≤0.05 are significant. A. Macrophage density, p=0.08. B. CD3+ cell density, p=0.04; *E+/+ vs E+/− and E−/−, p≤0.03; †E−/+ vs E+/− and E−/−, p≤0.05. C. CD8+ cell density, p=0.14. D. Dendritic cell density, p=0.8. E. Total cellularity, p=0.02; *E+/+ vs E+/−, p=0.03; †E−/+ vs E+/−, p=0.002.

Treatment group comparisons of cellular outcomes. Data are expressed as mean +/−SEM; p-values ≤0.05 are significant. A. Macrophage density, p=0.08. B. CD3+ cell density, p=0.04; *E+/+ vs E+/− and E−/−, p≤0.03; †E−/+ vs E+/− and E−/−, p≤0.05. C. CD8+ cell density, p=0.14. D. Dendritic cell density, p=0.8. E. Total cellularity, p=0.02; *E+/+ vs E+/−, p=0.03; †E−/+ vs E+/−, p=0.002.